Looking beyond surveillance, epidemiology, and end results: patterns of chemotherapy administration for advanced non-small cell lung cancer in a contemporary, diverse population.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Drew W RascoDavid E Gerber

Abstract

Chemotherapy prolongs survival without substantially impairing quality of life for medically fit patients with advanced non-small cell lung cancer (NSCLC), but population-based studies have shown that only 20 to 30% of these patients receive chemotherapy. These earlier studies have relied on Medicare-linked Surveillance, Epidemiology, and End Results (SEER) data, thus excluding the 30 to 35% of lung cancer patients younger than 65 years. Therefore, we determined the use of chemotherapy in a contemporary, diverse NSCLC population encompassing all patient ages. We performed a retrospective analysis of patients diagnosed with stage IV NSCLC from 2000 to 2007 at the University of Texas Southwestern Medical Center. Demographic, treatment, and outcome data were obtained from hospital tumor registries. The association between these variables was assessed using univariate analysis and multivariate logistic regression. In all, 718 patients met criteria for analysis. Mean age was 60 years, 58% were men, and 45% were white. Three hundred fifty-three patients (49%) received chemotherapy. In univariate analysis, receipt of chemotherapy was associated with age (53% of patients younger than 65 years versus 41% of patients aged 65 years and ol...Continue Reading

References

Jul 29, 1993·The New England Journal of Medicine·J Z AyanianA M Epstein
May 16, 2000·Chest·C C EarleJ C Weeks
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJane C Weeks
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emilio AlbaUNKNOWN Spanish Breast Cancer Research Group
Dec 22, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott D RamseyBonnie Donato
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Timothy R WassenaarJoan H Schiller
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
Jul 25, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kathleen LangDavid Thompson
Aug 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN NSCLC Meta-Analyses Collaborative Group
Sep 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cathy J BradleyCharles W Given
Nov 28, 2008·Clinical Colorectal Cancer·Daniel RenoufSharlene Gill
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony S RobbinsElizabeth M Ward
Sep 16, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jeffrey T YorioDavid E Gerber
Dec 3, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Daniel MorgenszternRamaswamy Govindan
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth A ChrischillesRobert H Fletcher

❮ Previous
Next ❯

Citations

Aug 19, 2007·BMC Medical Informatics and Decision Making·Haiwen Shi, James Lyons-Weiler
Nov 26, 2010·Breast Cancer Research : BCR·Allison W KurianChristina A Clarke
Sep 26, 2014·Journal of the National Cancer Institute·David E GerberSandi L Pruitt
Nov 5, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Krista L NoonanNevin Murray
Aug 27, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Cheryl HoJanessa Laskin
Dec 22, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·David E GerberYang Xie
Mar 19, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Bercin Kutluk CenikDavid E Gerber
Feb 7, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hai-Long ZhangXi-Wu Zhou
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Mieke J AartsValery E P P Lemmens
Feb 24, 2016·Expert Opinion on Pharmacotherapy·R FerraraE Bria
May 29, 2012·Patient Education and Counseling·David E GerberSimon J Craddock Lee
Jul 13, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Saiama N WaqarGideon M Blumenthal
Oct 14, 2016·European Journal of Cancer Care·N M RankinT Shaw
Feb 11, 2015·Journal of the National Cancer Institute·Andrew L LaccettiDavid E Gerber
Jul 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David E Gerber
Sep 2, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory A MastersUNKNOWN American Society of Clinical Oncology Clinical Practice
Apr 8, 2017·Expert Opinion on Pharmacotherapy·C HardinH Cheng
Feb 2, 2017·International Journal of Clinical Oncology·Hironori AshinumaIkuo Sekine
Sep 11, 2016·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Christina M LubertoElyse R Park
Jan 2, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Saad A KhanDavid E Gerber
Nov 26, 2021·Cancer Control : Journal of the Moffitt Cancer Center·Justyna DurślewiczDariusz Grzanka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
D M ParkinS S Devesa
© 2021 Meta ULC. All rights reserved